Author:
Krishna Rajesh,Bergman Arthur J.,Jin Bo,Garg Amit,Roadcap Brad,Chiou Rita,Dru James,Cote Josee,Laethem Tine,Wang Regina W.,Didolkar Varsha,Vets Eva,Gottesdiener Keith,Wagner John A.
Subject
Pharmacology (medical),Pharmacology
Reference21 articles.
1. Identification and characterization of anacetrapib, a novel cholesteryl ester transfer protein inhibitor [abstract];O'Neill;J Clin Lipidol,2007
2. Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating aldosterone levels;Forrest;Br J Pharmacol,2008
3. Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomized placebo-controlled phase 1 studies;Krishna;Lancet,2007
4. Multiple-dose pharmacodynamics and pharmacokinetics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects [published online ahead of print June 25, 2008];Krishna;Clin Pharmacol Ther
5. Pharmacokinetics and pharmacodynamics of single doses of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor in healthy subjects;Krishna;J Clin Lipidol,2007
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献